The Microglial Response to Neurodegenerative Disease

Wilbur M Song1, Marco Colonna1

  • 1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.

Advances in Immunology
|September 26, 2018
PubMed

Insights

Microglia, the brain's immune cells, show a common activation pattern in neurodegeneration. Their complex roles, both beneficial and detrimental, are increasingly linked to disease, though mouse models and human genetics present conflicting views.

Area of Science:

  • Neuroimmunology
  • Neurobiology
  • Cellular Neuroscience

Background:

  • Microglia are the primary immune cells in the central nervous system.
  • They exhibit dynamic changes in morphology and function following neurological insults.
  • Recent transcriptomics reveal conserved microglial activation signatures across diverse neurodegeneration models.

Purpose of the Study:

  • To review evidence for a common microglial response in neurodegeneration.
  • To explore pathways initiating and sustaining microglial activation.
  • To discuss the dual roles of activated microglia and insights from human genetic studies.

Main Methods:

  • Review of transcriptomics studies in neurodegeneration models.
  • Analysis of genetic association studies in human neurodegenerative diseases.
  • Integration of findings from murine models and human genetics.

Main Results:

  • A conserved microglial activation signature is observed across various neurodegeneration models.
  • Microglia play multifaceted roles, both protective and detrimental, in different disease contexts.
  • Human genetic studies highlight significant links between microglial genes and neurodegenerative diseases.

Conclusions:

  • Strong evidence supports a causal link between activated microglia function and neurodegeneration.
  • Discrepancies exist between findings in mouse models and human genetic data regarding microglial roles.
  • Further research is needed to reconcile these differences and understand microglial contributions to neurodegeneration.